EDN1 and Sepsis: Consistent with these reports, we demonstrated that Xuebijing effectively alleviated structural impairments and inflammation in the alveolar–capillary barrier and reduced circulating ET-1, VWF, IL-1β, IL-6, and TNF-α in CLP rats within 12 h after sepsis.